I don't know - but its not great for the share price. No coverage in the market where they are trying to derive the most income from.
Its very strange. No EndPts, no OA weekly - nadda.
- Forums
- ASX - By Stock
- PAR
- Potential Financial Implications of Yesterday's Results
Potential Financial Implications of Yesterday's Results, page-69
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
21.0¢ |
Change
0.015(7.69%) |
Mkt cap ! $73.55M |
Open | High | Low | Value | Volume |
20.5¢ | 21.0¢ | 20.0¢ | $216.0K | 1.057M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 143324 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.0¢ | 44935 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 138349 | 0.200 |
9 | 191984 | 0.195 |
15 | 199884 | 0.190 |
6 | 161140 | 0.185 |
16 | 784128 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.210 | 44935 | 3 |
0.215 | 132157 | 4 |
0.220 | 82155 | 7 |
0.225 | 31604 | 3 |
0.230 | 33834 | 4 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
NEWS
New gold and silver soil anomalies uncovered at Black Range, strengthening exploration potential
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
PAR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online